The 4AWOMAN program also aims to promote and support scientific research, focusing on the epidemiology and characteristics of breast and gynecological cancers in Madagascar, as well as investigating the potential therapeutic and palliative local plants.
Protocols with the Istituto Europeo di Oncologia - Qiagen, and the Buck Institute of Research of Aging, and the expertise of the members of the Scientific Committee are strategic factors for progress in the knowledge of cancer.
The information gathered from these research programs, together with the data collected by our medical teams on the field, will allow us to make the public authorities aware of the importance of defining a real policy for the fight against cancer and to proceed quickly to the creation of a national cancer register, necessary for planning future actions.
In order to improve our research activities, the Foundation has always worked to create new relationships with numerous scientific entities. All this information also allowed our doctors to understand the specificity of tumors here in Madagascar and adapt the treatment therapy to each particular case. The data collected until now have already underlined some remarkable differences between the disease here and in Europe.
We will constantly carry on research activities in order to improve the quality of our health service and to raise awareness in the international community about the size of the problem.
The Akbaraly Foundation training program was designed to increase the knowledge of Malagasy physicians and medical staff regarding breast and cervical cancer. These Malagasy health professionals are being trained abroad thanks to the support of the Foundation’s international partners. Once back in Madagascar, the international trainees will be working on raising awareness and training other professionals.
The data recollected on the Papilloma Virus (possible cause of cervical cancer), show a much higher percentage of positive tests in Madagascar compared to other European countries.
Italy: positivity to HPV Test – 8%
Madagascar: positivity to HPV Test – 23%
We don’t have enough data yet to demonstrate a specific assumption, but many of the cases we have treated have shown a particularly aggressive form of the disease. Moreover, the age of the women that are affected seems to be 10 or 15 years lower than in Europe.
• 7 isto-technicians
• 3 bio-technicians
• 7 cyto-technicians
• 5 cyto-pathologist
• 20 general surgeons
• 21 general physician (colposcopies)
• 2 doctors in palliative care
• 1 doctor in mammary ultrasound and mammography
• 2 doctors in ecography
• 5 doctors sent abroad for a long-term training.